-
1.
公开(公告)号:US09284543B2
公开(公告)日:2016-03-15
申请号:US13385527
申请日:2012-02-21
CPC分类号: C12N9/2408 , A61K38/00 , A61K47/60 , A61K47/61 , A61K47/6435 , C12N9/2474
摘要: Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.
摘要翻译: 提供可溶性PH20多肽,包括延长的可溶性PH20多肽及其应用。 还提供了其它C末端截短的PH20多肽和部分去糖基化的PH20多肽及其用途。
-
公开(公告)号:US20130101577A9
公开(公告)日:2013-04-25
申请号:US13385527
申请日:2012-02-21
IPC分类号: A61K38/47 , C12N9/96 , C12N15/63 , C12N5/10 , C12N1/21 , C12N1/19 , C12N1/15 , C12N15/56 , A61P25/00 , A61P35/00 , A61P27/02 , A61P9/00 , A61P29/00 , A61P9/12 , A61P31/10 , A61P33/04 , A61P31/00 , A61P25/16 , A61K39/395 , A61P33/06 , C12N9/26
CPC分类号: C12N9/2408 , A61K38/00 , A61K47/60 , A61K47/61 , A61K47/6435 , C12N9/2474
摘要: Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.
摘要翻译: 提供可溶性PH20多肽,包括延长的可溶性PH20多肽及其应用。 还提供了其它C末端截短的PH20多肽和部分去糖基化的PH20多肽及其用途。
-
公开(公告)号:US20120213767A1
公开(公告)日:2012-08-23
申请号:US13385527
申请日:2012-02-21
IPC分类号: A61K38/47 , C12N9/96 , C12N15/63 , C12N5/10 , C12N1/21 , C12N1/19 , C12N1/15 , C12N15/56 , A61P25/00 , A61P35/00 , A61P27/02 , A61P9/00 , A61P29/00 , A61P9/12 , A61P31/10 , A61P33/04 , A61P31/00 , A61P25/16 , A61K39/395 , A61P33/06 , C12N9/26
CPC分类号: C12N9/2408 , A61K38/00 , A61K47/60 , A61K47/61 , A61K47/6435 , C12N9/2474
摘要: Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.
摘要翻译: 提供可溶性PH20多肽,包括延长的可溶性PH20多肽及其应用。 还提供了其它C末端截短的PH20多肽和部分去糖基化的PH20多肽及其用途。
-
公开(公告)号:US08927249B2
公开(公告)日:2015-01-06
申请号:US12653245
申请日:2009-12-09
CPC分类号: C12N9/2408 , A61K38/00 , A61K47/60 , A61K47/61 , A61K47/6435 , C12N9/2474
摘要: Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.
摘要翻译: 提供可溶性PH20多肽,包括延长的可溶性PH20多肽及其应用。 还提供了其它C末端截短的PH20多肽和部分去糖基化的PH20多肽及其用途。
-
公开(公告)号:US08632770B2
公开(公告)日:2014-01-21
申请号:US12851651
申请日:2010-08-06
IPC分类号: A61K38/48
CPC分类号: A61K38/4846 , A61K47/549 , A61K47/60 , Y02A50/471
摘要: The present invention provides conjugates between Factor IX and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
摘要翻译: 本发明提供因子IX和PEG部分之间的缀合物。 缀合物通过插入和共价连接到肽和修饰基团之间的完整糖基连接基团连接。 通过糖基转移酶的作用,由糖基化肽形成缀合物。 糖基转移酶将修饰的糖部分连接到肽上的糖基残基上。 还提供了制备缀合物的方法,用缀合物治疗各种疾病状况的方法,以及包括缀合物的药物制剂。
-
公开(公告)号:US20100143457A1
公开(公告)日:2010-06-10
申请号:US12653245
申请日:2009-12-09
IPC分类号: A61K38/47 , C12N9/26 , C12N9/96 , C07H21/04 , C12N15/63 , C12N5/10 , A61K39/395 , A61K9/127 , A61K38/20 , A61K38/21 , A61P35/00
CPC分类号: C12N9/2408 , A61K38/00 , A61K47/60 , A61K47/61 , A61K47/6435 , C12N9/2474
摘要: Soluble PH20 polypeptides are provided, including extended soluble PH20 polypeptides, and uses thereof. Also provided are other C-terminally truncated PH20 polypeptides and partially deglycosylated PH20 polypeptides and uses thereof.
摘要翻译: 提供可溶性PH20多肽,包括延长的可溶性PH20多肽及其应用。 还提供了其它C末端截短的PH20多肽和部分去糖基化的PH20多肽及其用途。
-
-
-
-
-